Key result
Enalapril achieved lower systolic and diastolic blood pressures than verapamil at 1 month, though reductions were similar at 2 months.
Why the study?
Does enalapril improve blood pressure reduction compared to slow-release verapamil in patients with mild to moderate essential hypertension?
RCT (n=22)
Double-blind
Does enalapril improve blood pressure reduction compared to slow-release verapamil in patients with mild to moderate essential hypertension?
Enalapril and slow-release verapamil are equally effective and well-tolerated antihypertensive agents after 2 months of dose titration, though enalapril provides greater initial blood pressure reduction at starting doses.
Answers are grounded in this paper and cite their sources.
Enalapril may be preferred initially for faster BP control in essential hypertension; confirms equivalent efficacy to verapamil after 2-month titration.
The antihypertensive efficacy and tolerability of enalapril (E) and slow-release verapamil (V) were compared in a 2-month double-blind cross-over study in 22 patients with mild to moderate essential hypertension. After 1 month, significantly lower systolic (P less than 0.01) and diastolic (P less than 0.02) blood pressures (BP) were achieved with E, 20 mg d-1, compared with V, 240 mg d-1. After 2 months of treatment, BP reductions were similar after E, 40 mg d-1, and V, 240 mg twice a day. The fall in supine mean BP after 2 months of treatment with V was significantly greater in patients aged greater than or equal to 50 years of age (P = 0.02) (median 18 mmHg) than in patients aged less than 50 years (10 mmHg). E showed similar effectiveness in both age groups. Statistical group analysis of a quality-of-life questionnaire showed no significant differences between the active drugs and the placebo. It is concluded that E and V are equally effective as antihypertensive agents, and that both drugs are well tolerated.
No takes yet. Share an insight, caveat, or question.
Fagher et al. (1991) conducted an RCT in mild to moderate essential hypertension (n=22). Enalapril vs. Slow-release verapamil (240 to 480 mg/day) was evaluated on Systolic and diastolic blood pressure (p=<0.01). Enalapril achieved lower systolic and diastolic blood pressures than verapamil at 1 month, though reductions were similar at 2 months.
Synapse has enriched 10 related papers. Consider them for comparative context: